Identification and Characterization of the Binding Sites of P-Glycoprotein for Multidrug Resistance-Related Drugs and Modulators

Publisher： Bentham Science Publishers

E-ISSN： 1875-5968|4|1|1-17

ISSN： 1568-0118

Source： Current Medicinal Chemistry - Anti-Cancer Agents, Vol.4, Iss.1, 2004-01, pp. : 1-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structure of the multidrug resistance P-glycoprotein

By Higgins C.F.   Callaghan R.   Linton K.J.   Rosenberg M.F.   Ford R.C.  

Seminars in Cancer Biology, Vol. 8, Iss. 3, 1997-06 ,pp. : 135-142

Academic Press

Access to resources Recommend Favorite

Modulation of P-Glycoprotein (PGP) Mediated Multidrug Resistance (MDR) Using Chemosensitizers: Recent Advances in the Design of Selective MDR Modulators

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 1, Iss. 2, 2001-08 ,pp. : 163-174

Bentham Science Publishers

Access to resources Recommend Favorite

Increased P-glycoprotein expression in mitochondria is related to acquired multidrug resistance in human hepatoma cells depleted of mitochondrial DNA

By          

International Journal of Oncology, Vol. 40, Iss. 1, 2012-01 ,pp. : 109-118

Spandidos Publications

Access to resources Recommend Favorite

Phenothiazines and Related Drugs as Multi Drug Resistance Reversal Agents in Cancer Chemotherapy Mediated by p-glycoprotein

By  

Current Cancer Therapy Reviews, Vol. 13, Iss. 1, 2017-08 ,pp. : 28-42

Bentham Science Publishers

Access to resources Recommend Favorite

A Possibility to overcome P-glycoprotein (PGP)-mediated multidrug resistance by antibody-targeted drugs conjugated to N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer carrier

By St'astny   Strohalm J.   Plocova   Ulbrich K.   Rhova B.  

European Journal of Cancer, Vol. 35, Iss. 3, 1999-03 ,pp. : 459-466

Elsevier

Access to resources Recommend Favorite